Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CATHY B BARNES

Allopathic & Osteopathic Physicians Family Medicine

NPI
1821089756
CMS profile
309044
Location
TRINITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$1,292.30

10 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $938.42 4
Food and Beverage $353.88 6

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
ModernaTX, Inc. $1,292.30 10

Page 1 of 1; records 1–10 of 10 matching records. This page contains 10 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CATHY B BARNES

NPI 1821089756 · CMS profile ID 309044

Allopathic & Osteopathic Physicians / Family Medicine

TRINITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–10 of 10 matching records. This page contains 10 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821089756?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CATHY B BARNES, NPI 1821089756, CMS profile ID 309044. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–10 of 10 matching records. This page contains 10 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821089756?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CATHY B BARNES, NPI 1821089756, CMS profile ID 309044. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–10 of 10 matching records. This page contains 10 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821089756?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CATHY B BARNES, NPI 1821089756, CMS profile ID 309044, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–10 of 10 matching records. This page contains 10 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1821089756?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

10 matching records · $1,292.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 10 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–10 of 10.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ModernaTX, Inc. $47.8809/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557889 CMS
ModernaTX, Inc. $240.0009/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557899 CMS
ModernaTX, Inc. $354.9609/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557917 CMS
ModernaTX, Inc. $77.9309/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557925 CMS
ModernaTX, Inc. $265.5309/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557929 CMS
ModernaTX, Inc. $120.0009/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557989 CMS
ModernaTX, Inc. $45.0009/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557991 CMS
ModernaTX, Inc. $30.0009/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557993 CMS
ModernaTX, Inc. $81.0009/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557995 CMS
ModernaTX, Inc. $30.0009/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152557997 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $242.96 3
PY2020 $2,414.87 43
PY2021 $102.51 1
PY2022 $81.28 1
PY2024 $1,292.30 10
PY2025 $1,335.09 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $3,205,743.80 119
PY2024 Recipient $34,906.00 2
PY2024 Principal investigator $2,451,942.71 49
PY2023 Recipient $2,790.56 3
PY2023 Principal investigator $2,713,362.43 33
PY2022 Recipient $28,555.00 4
PY2022 Principal investigator $1,298,287.06 112
PY2021 Principal investigator $858,224.34 839
PY2020 Recipient $142.50 1
PY2020 Principal investigator $353,224.47 119
PY2019 Recipient $12,826.75 13
PY2019 Principal investigator $389,491.61 41

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

116 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,038.50 12/31/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889827519
Principal investigator 1 ABBVIE INC. $77.25 12/31/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants No dispute reported 06/30/2026 965540107
Principal investigator 1 ABBVIE INC. $6,792.22 12/07/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889823357
Principal investigator 1 ABBVIE INC. $7,064.31 11/08/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889818643
Principal investigator 1 Eli Lilly and Company $117,158.00 10/18/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY MEASURED BY AMYLOID REDUCTION OF LY3372993 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917843019
Principal investigator 1 ABBVIE INC. $19,142.47 10/11/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889814111
Principal investigator 1 Novo Nordisk AS $478.12 09/30/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896958311
Principal investigator 1 ABBVIE INC. $4,651.91 09/08/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889809377
Principal investigator 1 Novo Nordisk AS $433.12 08/22/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896924775
Principal investigator 1 ABBVIE INC. $4,339.57 08/04/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889803435
Principal investigator 1 Novo Nordisk AS $1,578.37 07/27/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896976653
Principal investigator 1 Eli Lilly and Company $6,782.00 07/06/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY MEASURED BY AMYLOID REDUCTION OF LY3372993 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917843007
Principal investigator 1 Novo Nordisk AS $1,533.37 06/29/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896976649
Principal investigator 1 ABBVIE INC. $8,708.12 06/21/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889796465
Principal investigator 1 Eli Lilly and Company $168,327.00 06/07/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 COMPARED WITH INSULIN DEGLUDEC IN PARTICIPANTS WITH TYPE 2 DIABETES CURRENTLY TREATED WITH BASAL INSULIN (QWINT-3) No dispute reported 06/30/2026 917840483
Principal investigator 1 ABBVIE INC. $10,500.00 05/26/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine No dispute reported 06/30/2026 889792735
Principal investigator 1 Eli Lilly and Company $413,947.00 05/17/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3372689 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917833361
Recipient Eli Lilly and Company $11,478.00 04/29/2022 Covered Recipient Physician A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 COMPARED WITH INSULIN DEGLUDEC IN PARTICIPANTS WITH TYPE 2 DIABETES CURRENTLY TREATED WITH BASAL INSULIN (QWINT-3) No dispute reported 06/30/2026 917809071
Principal investigator 1 Novo Nordisk AS $1,000.00 04/29/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896931325
Principal investigator 1 Novo Nordisk AS $694.12 04/29/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982041
Principal investigator 1 Novo Nordisk AS $250.00 04/29/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897010111
Recipient Eli Lilly and Company $8,689.00 04/08/2022 Covered Recipient Physician A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917809147
Recipient Eli Lilly and Company $2,944.00 04/08/2022 Covered Recipient Physician A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917809729
Recipient Eli Lilly and Company $5,444.00 04/01/2022 Covered Recipient Physician ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3372689 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917809077
Principal investigator 1 Eli Lilly and Company $1,120.00 03/30/2022 Non-covered Recipient Entity
MARIN ENDOCRINE CARE AND RESEARCH
A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 COMPARED WITH INSULIN DEGLUDEC IN PARTICIPANTS WITH TYPE 2 DIABETES CURRENTLY TREATED WITH BASAL INSULIN (QWINT-3) No dispute reported 06/30/2026 917827589
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896861025
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896861027
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896861029
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896861031
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896924721
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896924777
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896924785
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896931322
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896931329
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896931333
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896931337
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896958299
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896958303
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896958307
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896976639
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896976643
Principal investigator 1 Novo Nordisk AS $694.12 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896976647
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896981975
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982033
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982045
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982049
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982053
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896982057
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896991479
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992363
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992367
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992371
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992375
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992379
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992383
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992387
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897000574
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897000681
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897000733
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897000737
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897010115
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897010329
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897010333
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019155
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019159
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019163
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019167
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019171
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019175
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019179
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019183
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019187
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897019247
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029436
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029439
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029443
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029447
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029451
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897029455
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897075319
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897075323
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897076155
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897076159
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897076163
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897076167
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897076171
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897077333
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897077971
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897078115
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897078484
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123315
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123347
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123351
Principal investigator 1 Novo Nordisk AS $22.76 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123355
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123359
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123363
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123375
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123379
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897123421
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125795
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125799
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125803
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125807
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125811
Principal investigator 1 Novo Nordisk AS $120.00 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897125815
Principal investigator 1 Novo Nordisk AS $5.50 03/25/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 897131853
Principal investigator 1 Eli Lilly and Company $7,300.00 03/15/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 917843261
Principal investigator 1 Allergan, Inc. $1,252.40 03/08/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE TREATMENT OF MIGRAINE WHEN ADMINSTERED DURING THE PREMONITORY PHASE No dispute reported 06/30/2026 864374415
Principal investigator 1 Eli Lilly and Company $6,598.00 02/14/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 COMPARED WITH INSULIN DEGLUDEC IN PARTICIPANTS WITH TYPE 2 DIABETES CURRENTLY TREATED WITH BASAL INSULIN (QWINT-3) No dispute reported 06/30/2026 917842431
Principal investigator 1 Novo Nordisk AS $862.87 02/07/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4481 No dispute reported 06/30/2026 896992359
Principal investigator 1 Eli Lilly and Company $6,526.00 01/27/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3372689 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917843267
Principal investigator 1 Allergan, Inc. $915.80 01/12/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE TREATMENT OF MIGRAINE WHEN ADMINSTERED DURING THE PREMONITORY PHASE No dispute reported 06/30/2026 864367325
Principal investigator 1 Eli Lilly and Company $168,634.00 01/11/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917840462
Principal investigator 1 Eli Lilly and Company $3,014.00 01/11/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917840479
Principal investigator 1 Eli Lilly and Company $3,464.00 01/11/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917842437
Principal investigator 1 Eli Lilly and Company $320,986.00 01/04/2022 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917840457